Vita 34 AG V3V
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €4.30
- Day Range
- €4.24–4.40
- 52-Week Range
- €4.26–17.40
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €74.96 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 49.45
- Price/Sales
- 0.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group’s reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Stock Style Box
- Small Core
- Total Number of Employees
- 758
- Website
- https://www.vita34.de
Comparables
Valuation
|
Metric
|
V3V
|
1784
|
CORBF
|
|---|---|---|---|
Price/Earnings (Normalized) | 49.45 | 73.76 | — |
Price/Book Value | 3.25 | 4.39 | — |
Price/Sales | 0.89 | 4.48 | — |
Price/Cash Flow | 6.75 | 47.72 | — |
Price/Earnings
V3V
1784
CORBF
Financial Strength
|
Metric
|
V3V
|
1784
|
CORBF
|
|---|---|---|---|
Quick Ratio | 0.65 | 3.77 | 10.64 |
Current Ratio | 0.71 | 4.02 | 10.73 |
Interest Coverage | −2.08 | 101.79 | — |
Quick Ratio
V3V
1784
CORBF
Profitability
|
Metric
|
V3V
|
1784
|
CORBF
|
|---|---|---|---|
Return on Assets (Normalized) | 1.11% | 3.11% | 6.40% |
Return on Equity (Normalized) | 9.04% | 6.25% | 11.37% |
Return on Invested Capital (Normalized) | 3.86% | 3.51% | 10.76% |
Return on Assets
V3V
1784
CORBF
Medical Care Facilities Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| HCA Healthcare Inc
HCA
| Hqrybldk | Hvvdcgm | $101.7 Bil | |||
| Fresenius SE & Co KGaA ADR
FSNUY
| — | Kbvjqtv | $21.1 Bil | |||
| Fresenius SE & Co KGaA
FSNUF
| — | Fdwbqs | $21.1 Bil | |||
| Tenet Healthcare Corp
THC
| Wmbnbpt | Tqkq | $15.0 Bil | |||
| Universal Health Services Inc Class B
UHS
| — | Gkndwn | $14.4 Bil | |||
| Bangkok Dusit Medical Services PCL ADR
BDUUY
| — | Xpfr | $14.1 Bil | |||
| DaVita Inc
DVA
| Jckfkcgx | Jbryv | $13.5 Bil | |||
| Fresenius Medical Care AG
FMCQF
| — | Fxwtw | $12.2 Bil | |||
| Fresenius Medical Care AG ADR
FMS
| Zmsm | Rlsblqp | $12.2 Bil | |||
| Encompass Health Corp
EHC
| — | Yjycfvf | $9.5 Bil |
United States